Home Data Calendar Blog

FHTX

Tables

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Weighted Average Number Of Diluted Shares Outstanding 42.43 NA 42.03 41.83 41.81 NA 41.67 41.52 41.37 NA 36.97 36.85 36.82 NA 5.88

Weighted Average Number Of Shares Outstanding Basic 42.43 NA 42.03 41.83 41.81 NA 41.67 41.52 41.37 NA 36.97 36.85 36.82 NA 5.88

Earnings Per Share Basic -0.59 -0.57 -0.34 -0.70 -0.73 -0.69 -0.62 -0.66 -0.65 -0.77 -0.71 -0.63 -0.62 2.53 -3.15

Earnings Per Share Diluted -0.59 -0.57 -0.34 -0.70 -0.73 -0.69 -0.62 -0.66 -0.65 -0.77 -0.71 -0.63 -0.62 2.53 -3.12

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Revenue From Contract With Customer Excluding Assessed Tax 5.05 5.77 17.48 5.60 5.31 4.18 6.63 4.49 3.92 0.71 0.04 0.28 0.29 0.25 0.18

Revenues 5.05 5.77 17.48 5.60 5.31 4.18 6.63 4.49 3.92 0.71 0.04 0.28 0.29 0.25 0.18

Operating Expenses 33.24 31.23 34.56 37.65 38.63 36.07 34.89 33.68 31.72 28.80 26.30 23.54 23.42 21.03 18.67

Research And Development Expense 25.53 24.20 26.25 29.25 29.98 28.21 26.93 25.97 24.51 22.46 20.49 18.64 18.73 16.47 16.11

General And Administrative Expense 7.71 7.02 8.31 8.40 8.64 7.86 7.96 7.70 7.22 6.33 5.81 4.90 4.69 4.56 2.56

Operating Income Loss -28.19 -25.46 -17.08 -32.05 -33.32 -31.89 -28.26 -29.19 -27.80 -28.08 -26.26 -23.26 -23.13 -20.78 -18.49

Income Tax Expense Benefit NA 1.99 0.74 0.94 0.56 NA NA NA NA NA NA NA NA NA NA

Income Taxes Paid Net 0.05 NA 1.00 NA NA NA NA NA NA NA NA NA NA NA NA

Net Income Loss -25.02 -24.11 -14.35 -29.49 -30.49 -28.89 -25.77 -27.31 -26.91 -29.14 -26.08 -23.11 -22.99 -20.76 -18.37

Comprehensive Income Net Of Tax -24.69 -23.04 -13.52 -29.34 -29.37 -28.01 -27.44 -29.31 -28.10 -29.14 -26.08 -23.13 -22.97 -20.77 -18.37

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Assets 255.00 285.92 313.42 339.58 372.88 404.88 433.93 456.90 488.31 519.77 186.07 208.53 229.89 255.59 142.43

Liabilities 352.49 363.11 370.81 388.93 397.47 404.77 409.61 409.27 415.90 422.90 105.09 104.34 104.72 109.41 99.35

Liabilities And Stockholders Equity 255.00 285.92 313.42 339.58 372.88 404.88 433.93 456.90 488.31 519.77 186.07 208.53 229.89 255.59 142.43

Stockholders Equity -97.49 -77.19 -57.39 -49.35 -24.59 0.11 24.32 47.63 72.40 96.87 80.98 104.19 125.16 146.19 -133.32

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Assets Current 211.52 240.18 265.44 290.49 320.70 351.40 377.76 400.07 429.82 459.56 123.95 144.67 165.31 190.69 77.76

Cash And Cash Equivalents At Carrying Value 79.25 80.34 70.31 57.70 50.64 52.21 87.60 61.21 213.65 101.14 57.84 125.17 66.45 92.80 74.62

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 80.96 82.04 72.01 59.41 52.35 53.92 89.34 62.94 215.38 102.87 59.57 126.90 68.18 94.53 76.89

Prepaid Expense And Other Assets Current 4.86 6.12 5.55 6.18 4.73 5.60 4.24 5.34 5.09 5.27 3.11 3.40 4.40 4.92 2.60

Available For Sale Securities Debt Securities 127.41 153.72 189.58 226.61 265.33 293.58 285.89 333.52 211.09 53.15 63.00 16.11 94.47 92.97 NA

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Other Assets Noncurrent 1.05 1.11 1.13 1.17 2.36 2.38 2.37 2.38 2.40 2.40 2.43 2.44 1.60 0.84 0.21

Available For Sale Debt Securities Amortized Cost Basis 127.91 154.55 191.47 229.33 268.20 297.57 290.76 336.71 212.29 53.16 63.01 16.12 94.46 92.98 NA

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Liabilities Current 52.06 58.44 52.01 56.64 55.80 55.20 55.21 47.97 48.24 48.69 19.30 16.41 16.33 18.85 21.30

Accounts Payable Current 5.63 6.26 6.50 6.93 7.29 5.41 5.26 3.63 5.07 3.82 3.82 3.41 2.91 3.68 3.55

Other Accrued Liabilities Current NA 0.04 0.30 0.09 0.14 0.32 0.32 0.27 0.23 0.38 0.11 0.00 0.14 0.14 0.59

Accrued Liabilities Current 6.26 9.11 8.80 8.14 8.83 11.00 10.12 8.10 7.01 9.56 NA 5.15 5.13 9.16 9.97

Contract With Customer Liability Current 31.50 34.55 28.34 33.90 33.33 32.82 33.16 30.57 30.06 28.32 1.28 0.91 2.41 2.02 NA

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Operating Lease Liability Noncurrent 34.31 36.55 38.71 40.27 43.49 45.54 46.50 49.14 50.48 51.34 53.02 54.80 56.55 58.36 56.01

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Stockholders Equity -97.49 -77.19 -57.39 -49.35 -24.59 0.11 24.32 47.63 72.40 96.87 80.98 104.19 125.16 146.19 -133.32

Additional Paid In Capital 399.59 395.20 391.96 386.48 381.91 377.23 373.44 369.30 364.76 361.13 316.10 313.23 311.08 309.13 8.85

Retained Earnings Accumulated Deficit -496.58 -471.56 -447.46 -433.11 -403.63 -373.14 -344.25 -318.48 -291.17 -264.26 -235.11 -209.03 -185.92 -162.94 -142.18

Accumulated Other Comprehensive Income Loss Net Of Tax -0.50 -0.83 -1.89 -2.72 -2.87 -3.99 -4.86 -3.19 -1.19 -0.01 -0.01 -0.01 0.01 -0.01 NA

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 3.22 NA 4.09 4.47 4.57 NA 3.80 3.51 3.24 NA 2.37 2.04 1.89 1.08 0.88

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Net Cash Provided By Used In Operating Activities -29.34 -27.54 -27.21 -32.17 -31.18 -28.92 -19.99 -29.01 271.53 11.88 -20.50 -18.48 -23.15 -10.65 2.73

Net Cash Provided By Used In Investing Activities 27.09 37.38 38.43 39.13 29.50 -6.51 46.05 -124.46 -159.41 9.67 -47.33 77.09 -3.26 -100.22 -5.42

Net Cash Provided By Used In Financing Activities 1.17 0.19 1.39 0.10 0.10 0.02 0.33 1.03 0.38 21.74 0.51 0.11 0.06 128.51 40.75

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Net Cash Provided By Used In Operating Activities -29.34 -27.54 -27.21 -32.17 -31.18 -28.92 -19.99 -29.01 271.53 11.88 -20.50 -18.48 -23.15 -10.65 2.73

Net Income Loss -25.02 -24.11 -14.35 -29.49 -30.49 -28.89 -25.77 -27.31 -26.91 -29.14 -26.08 -23.11 -22.99 -20.76 -18.37

Depreciation Depletion And Amortization 0.83 0.85 0.90 0.80 0.86 0.85 0.90 0.80 0.81 0.81 0.80 0.80 0.77 0.56 0.30

Increase Decrease In Accounts Payable -0.63 -0.24 -0.44 -0.17 1.69 0.16 1.62 -1.44 1.27 -0.02 0.41 0.49 -0.75 0.85 -0.09

Share Based Compensation 3.22 3.05 4.09 4.47 4.57 3.78 3.80 3.51 3.24 2.09 2.37 2.04 1.89 1.08 0.88

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Net Cash Provided By Used In Investing Activities 27.09 37.38 38.43 39.13 29.50 -6.51 46.05 -124.46 -159.41 9.67 -47.33 77.09 -3.26 -100.22 -5.42

Payments To Acquire Property Plant And Equipment 0.10 0.04 0.08 0.47 0.64 0.27 0.33 0.36 0.25 0.08 0.23 1.21 1.79 7.49 5.42

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Net Cash Provided By Used In Financing Activities 1.17 0.19 1.39 0.10 0.10 0.02 0.33 1.03 0.38 21.74 0.51 0.11 0.06 128.51 40.75

2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30

Revenues 5.05 5.77 17.48 5.60 5.31 4.18 6.63 4.49 3.92 0.71 0.04 0.28 0.29 0.25 0.18

Eli Lilly 5.10 5.80 1.40 5.20 4.70 4.10 5.30 4.20 3.80 NA NA NA NA NA NA

Eli Lilly, Related Party 1.70 NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Revenue From Contract With Customer Excluding Assessed Tax 5.05 5.77 17.48 5.60 5.31 4.18 6.63 4.49 3.92 0.71 0.04 0.28 0.29 0.25 0.18

Eli Lilly 5.10 5.80 1.40 5.20 4.70 4.10 5.30 4.20 3.80 NA NA NA NA NA NA

Eli Lilly, Related Party 1.70 NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Plots across concepts

IncomeStatement

Operating Income Loss

Expenses

Income Tax Expense Benefit

Balance Sheet

Stockholders Equity

Assets

Operating Lease Right Of Use Asset

Current Assets

Prepaid Expense And Other Assets Current

NonCurrent Assets

Other Assets Noncurrent

Liabilities

Operating Lease Liability

Current Liabilities

Other Accrued Liabilities Current

Noncurrent Liabilities

Operating Lease Liability Noncurrent

Stockholders Equity

Retained Earnings Accumulated Deficit

CashFlow

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInInvestingActivities

Payments To Acquire Property Plant And Equipment

Shares

Weighted Average Number Of Diluted Shares Outstanding

OperatingLeaseLiability

Operating Lease Liability Current

LesseeOperatingLeaseLiabilityPaymentsDue

Lessee Operating Lease Liability Undiscounted Excess Amount

Line plots across dimensions of each concept